BioNTech COVID-19 (BNT162b2) Vaccination and Varicella Zoster Reactivation: A Comprehensive Cross-sectional Study.

Authors:
Azrielant S; Levin Y; Peled A; Samuelov L; Sprecher E and 1 more

Journal:
Acta Derm Venereol

Publication Year: 2024

DOI:
10.2340/actadv.v104.18389

PMCID:
PMC10875474

PMID:
38348725

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Derm Venereol

Abbreviation: Acta Derm Venereol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Sexually Transmitted Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Child with a Lump in the Neck: A Quiz.
Van Gysel D; Janmohamed SR; Locy H and 2 more (2024) - Transparency Score: 1/6
A Child with Hoarseness and Recurrent Cheek Erosions: A Quiz.
Song D; Wang S. (2024) - Transparency Score: 1/6
Adult Acne in Middle-age: Effects on Mental Health in General Population of the Northern Finland Bi…
Leskelä M; Jokelainen J; Huilaja L and 1 more (2024) - Transparency Score: 2/6
A Rare Case of Primary Cutaneous Basaloid Squamous Cell Carcinoma of the Finger.
Kim HS; Choi WG; Lee SK and 2 more (2024) - Transparency Score: 2/6
Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese P…
Numata T; Irisawa R; Mori M and 2 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest MP received research support from Pfizer. ES received consulting fees from Pierre Fabre, Kamari, Biomx, Bayer, Amryt, Krystal, Sol-Gel, BiondVax and received many grants, none of which are relevant to this work. LS received consulting fees from Pfizer and participated in its industry boards."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025